Volume | 821,939 |
|
|||||
News | - | ||||||
Day High | 4.625 | Low High |
|||||
Day Low | 4.45 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Vanda Pharmaceuticals Inc | VNDA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
4.57 | 4.45 | 4.625 | 4.62 | 4.48 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
7,023 | 821,939 | US$ 4.57 | US$ 3,758,600 | - | 3.295 - 7.00 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
16:46:57 | formt | 170 | US$ 4.5199 | USD |
Vanda Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
265.25M | 57.54M | - | 192.64M | 2.51M | 0.04 | 105.73 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Vanda Pharmaceuticals News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VNDA Price Data
Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.96 | 5.30 | 4.43 | 4.79 | 1,660,856 | -0.4401 | -8.87% |
1 Month | 4.23 | 6.03 | 3.87 | 4.98 | 5,487,012 | 0.2899 | 6.85% |
3 Months | 3.69 | 6.03 | 3.46 | 4.74 | 2,446,800 | 0.8299 | 22.49% |
6 Months | 4.28 | 6.03 | 3.295 | 4.48 | 1,635,729 | 0.2399 | 5.61% |
1 Year | 6.25 | 7.00 | 3.295 | 4.77 | 1,267,925 | -1.73 | -27.68% |
3 Years | 17.10 | 21.8627 | 3.295 | 8.03 | 756,605 | -12.58 | -73.57% |
5 Years | 16.62 | 21.8627 | 3.295 | 9.86 | 694,507 | -12.10 | -72.80% |
Vanda Pharmaceuticals Description
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include Tradipitant (VLY-686), VTR-297, and VQW-765. |